Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study
Go back to Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study| Chugai Pharmaceutical Ltd Unsponsored ADR (AMEX: CHGCY) | Delayed: 21.47 -0.19 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.66 | 52 Week High | $74.63 | |||
| Open | $21.27 | 52 Week Low | $56.80 | |||
| Day High | $21.70 | P/E | N/A | |||
| Day Low | $20.94 | EPS | $0.00 | |||
| Volume | 146,476 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 55.06 -0.6 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.66 | 52 Week High | $35.13 | |||
| Open | $55.65 | 52 Week Low | $28.10 | |||
| Day High | $55.87 | P/E | N/A | |||
| Day Low | $54.74 | EPS | $0.00 | |||
| Volume | 1,295,052 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
